secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zivo Bioscience, Inc. (ZIVO)
CIK:        0001101026
Form:       8-K
Filed at:   2024-01-17T23:59:59+00:00
Accession:  0001654954-24-000694
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Zivo Bioscience sells 174,145 unregistered shares to accredited investors at avg $3.05/share
--------------------------------------------------------------------------------

- Sold 174,145 common shares at $2.82–$4.02 each (avg $3.05), relying on Section 4(2) and Regulation D.
- No underwriter discounts or commissions; transaction exempt from registration under Securities Act.
- As of Jan 16, 2024, outstanding common shares totaled 2,748,167.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1101026/000165495424000694/0001654954-24-000694-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1101026/000165495424000694/zivo_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-000694

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer